A heparin-modified thermoresponsive surface with heparin-binding epidermal growth factor-like growth factor for maintaining hepatic functions in vitro and harvesting hepatocyte sheets  by Arisaka, Yoshinori et al.
lable at ScienceDirect
Regenerative Therapy 3 (2016) 97e106Contents lists avaiRegenerative Therapy
journal homepage: http: / /www.elsevier .com/locate/rethOriginal articleA heparin-modiﬁed thermoresponsive surface with heparin-binding
epidermal growth factor-like growth factor for maintaining hepatic
functions in vitro and harvesting hepatocyte sheets
Yoshinori Arisaka, Jun Kobayashi*, Kazuo Ohashi, Kohei Tatsumi, Kyungsook Kim,
Yoshikatsu Akiyama, Masayuki Yamato, Teruo Okano**
Institute of Advanced Biomedical Engineering and Science and Global Center of Excellence (COE) Program, Tokyo Women's Medical University (TWIns),
8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japana r t i c l e i n f o
Article history:
Received 1 December 2015
Received in revised form
8 March 2016
Accepted 8 March 2016
Keywords:
Poly(N-isopropylacrylamide)
Thermoresponsive cell culture surface
Heparin
Heparin-binding EGF-like growth factor
Hepatocyte sheetAbbreviations: IPAAm, N-isopropylacrylamide; CIP
ﬁbroblast growth factor; HB-EGF, heparin-binding
carboxyisopropylacrylamide) on TCPS; heparin-IC, h
EGF; NHS, N-hydroxysuccinimide; EDC, 1-ethyl-3-(3-
cellular matrix; DMEM, Dulbecco's modiﬁed Eagle's m
serum; Alb, albumin; Hnf4a, hepatocyte nuclear facto
reverse transcription polymerase chain reaction.
* Corresponding author. Tel.: þ81 3 5367 9945x621
** Corresponding author. Tel.: þ81 3 5367 9945x620
E-mail addresses: kobayashi.jun@twmu.ac.jp (J. Ko
Peer review under responsibility of the Japanese
http://dx.doi.org/10.1016/j.reth.2016.03.003
2352-3204/© 2016, The Japanese Society for Regener
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
A heparin-modiﬁed thermoresponsive surface bound with heparin-binding epidermal growth factor-like
growth factor (HB-EGF) was designed to allow creation of transferrable and functional hepatocyte sheets.
A heparin-modiﬁed thermoresponsive surface was prepared by covalently tethering heparin onto
poly(N-isopropylacrylamide-co-2-carboxyisopropylacrylamide)-grafted tissue culture polystyrene sur-
faces (Heparin-IC). HB-EGFs were able to stably bind to heparin-IC via afﬁnity interaction. The survival of
primary rat hepatocytes was maintained through HB-EGF-bound heparin-IC (HB-EGF/heparin-IC).
Moreover, cultured rat primary hepatocytes on HB-EGF/heparin-IC exhibited higher albumin-secretion
than hepatocytes cultured on PIPAAm-grafted and collagen-coated surfaces with soluble HB-EGF in
the culture medium, regardless of whether soluble EGF was added. These results suggested that HB-EGF/
heparin-IC is able to effectively maintain hepatic function via continuous signaling of HB-EGF. After a 4-
day cultivation, the cultured hepatocytes on HB-EGF/heparin-IC detached as a cell sheet with ﬁbronectin
and HB-EGF only after the temperature was lowered to 20 C. In addition, higher expression of
hepatocyte-speciﬁc genes (albumin, hepatocyte nuclear factor 4 alpha, coagulation factor VII, and
coagulation factor IX) in hepatocyte sheets was detected on HB-EGF/heparin-IC than on a PIPAAm surface
with soluble HB-EGF, indicating that HB-EGF/heparin-IC suppressed the dedifferentiation of cultured
hepatocytes. Hence, heparin-modiﬁed thermoresponsive surfaces bound with HB-EGF facilitate the
fabrication of transferrable hepatocyte sheets with intact hepatic functions and have the potential to
provide an in vitro culture system using functional hepatocyte sheet tissues, which may serve as an
effective hepatocyte-based tissue engineering platform for liver disease treatments.
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Cellular responses including survival, division, differentiation,
and apoptosis are regulated by extracellular signalingmolecules via
receptors on the cellular membrane [1]. Stimulation with the
extracellular signaling molecules such as extracellular matrices
(ECMs), growth factors, and cytokines triggers intracellular signal
transduction and subsequent cellular responses. In conventional
cell culture method, soluble signaling molecules including growth
factors and cytokines are supplemented in culture medium. How-
ever, the frequent dosing of the soluble molecules is required for
maintaining the stimulation of cells because of the down-
regulation through the endocytosis of the receptors [2]. Covalent
immobilization of growth factors and/or ECMs on cell culture sur-
faces facilitates the long-term stimulation of the receptors without
the down-regulation of the receptors [2,3], leading to improved cell
growth and maintenance of differentiated state. However, isolation
and passage processes using enzymatic treatments such as trypsi-
nization may induce irreversible damage of the receptors, resulting
in the reduction of cellular functions [4].
In order to harvest cultured cells nonenzymatically with
maintaining cellular functions, our laboratory reported a new
type of stimuli-responsive surface that was co-immobilized with
ECMs and growth factors [5]. Recently, we designed thermores-
ponsive poly(N-isopropylacrylamide) (PIPAAm)-grafted surfaces
modiﬁed with heparin molecules for switching of sustained
stimulation and detachment of cultured cells [6,7]. Heparin has
afﬁnity interactions with bioactive molecules such as growth
factors, ECMs, and protease [8]. Immobilized heparin on
shrunken PIPAAm chains at 37 C was able to bind basic ﬁbroblast
growth factor (bFGF), a heparin-binding growth factor. This
heparin-modiﬁed surface stabilizes and reinforces the formation
of a complex between immobilized heparin and bFGF, thus
leading to sustained stimulation of cultured ﬁbroblasts by bFGF
and rapid formation of a ﬁbroblast sheet. At 20 C, by contrast,
bound bFGF were released with the cultured ﬁbroblast sheet due
to the dynamic motion of heparin accompanied with the swelling
of hydrated PIPAAm chains. Thus, the switch from cell prolifera-
tion to cell detachment occurred only after the temperature was
changed [6].
In present paper, we focused on the cultivation of hepatocytes
on the heparin-modiﬁed thermoresponsive surfaces. We have
previously succeeded in the fabrication and subcutaneous trans-
plantation of hepatocyte sheets [9,10]. However, it is difﬁcult to
culture functional primary hepatocytes because the hepatocytes
rapidly lose their speciﬁc function as the cultivation time is
increased. In previous studies, the long-term maintenance of he-
patic morphologies and functions have been achieved by co-
culturing with nonparenchymal cells [11] and using ECMs such as
collagen [12] and Matrigel [13]. However, the conventional culture
systems for hepatocytes are not suitable for manipulation and
transplantation. In contrast, co-culturing of hepatocyte sheets with
nonparenchymal cells, including endothelial cells, on thermores-
ponsive cell culture surfaces with two-dimensional micro-
patterning [14] or three-dimensional layering techniques [15]
facilitates both the transfer and the functional maintenance of
hepatocytes. One of the reasons for this maintenance of hepatic
functions is considered to be the continuous stimulation of cellular
signaling by bioactive molecules containing growth factors, which
are continuously secreted from nonparenchymal cells. If the
signaling for the activation of hepatocytes were to continuously be
supplied from immobilized growth factors on thermoresponsive
cell culture surfaces, the cultured hepatocyte sheet would be able to
effectively maintain its functions. In addition, the creation of
transplantable hepatocyte sheets with high hepatic functionalitywould lead to an improvement in the quality of cell-sheet based
therapies for liver diseases.
The purpose of this study was the development of a functional
thermoresponsive cell culture system that maintains hepatocyte
speciﬁc functions without non-parenchymal cells and allows for
the recovery of a cell sheet. Under typical culture conditions of
hepatocytes and their sheets, the addition of soluble EGF, a potent
hepatocyte mitogen [16,17], to the culture medium is essential for
hepatocyte survival. Here, we utilize afﬁnity-immobilization of
heparin-binding epidermal growth factor-like growth factor (HB-
EGF), which has the ability to bind to heparinwith a speciﬁc afﬁnity
interaction [18e20] on a heparin-modiﬁed thermoresponsive sur-
face for the maintenance of hepatic function. HB-EGF activates EGF
receptors (ErbB1 and ErbB4) and, similarly to EGF, acts as a potent
hepatocyte mitogen [21e24]. In this study, rat primary hepatocytes
were cultured on a heparin-modiﬁed thermoresponsive surface
with HB-EGF, and the hepatic function was investigated. To
demonstrate the effectiveness of afﬁnity-bound HB-EGF in a he-
patocyte culture, two culture conditions were examined as follows:
1) hepatocytes on an HB-EGF-bound heparin-modiﬁed thermor-
esponsive surface (Fig. 1a) and 2) hepatocytes on a thermores-
ponsive surface in a culture medium containing heparin and
soluble HB-EGF (Fig. 1b). The albumin secretion of hepatocytes
under each condition was determined by enzyme-linked immu-
nosorbent assay (ELISA). After a 4-day cultivation, the hepatocytes
were detached as a cell sheet from each of the surfaces. To evaluate
the cell function of each hepatocyte sheet, several hepatic mRNA
expression levels were determined by quantitative reverse tran-
scription polymerase chain reaction (RT-PCR) analyses.
2. Experimental section
2.1. Chemicals and materials
N-Isopropylacrylamide (IPAAm) was obtained from Kohjin
(Tokyo, Japan) and puriﬁed by recrystallization from n-hexane. 2-
Carboxyisopropylacrylamide (CIPAAm) was synthesized using the
method described previously [25]. Tissue culture polystyrene dishes
(TCPS) (Nunc™, culture area: 8.8 cm2) were purchased from Thermo
Fisher Scientiﬁc (Roskilde, Denmark). N-Hydroxysuccinimide (NHS),
1-ethyl-3-(3-dimetylaminopropyl)-carbodiimide hydrochloride
(EDC), Triton-X 100, 2-propanol, dexamethasone, and insulin were
purchased from Wako Pure Chemicals (Osaka, Japan) and used as
received. 2-Morpholinoethanesulfonic acid monohydrate (MES) was
purchased from Dojindo (Kumamoto, Japan). Heparin sodium salt
from porcine intestinal mucosa (grade I-A, 180 USP units/mg), Dul-
becco's modiﬁed Eagle's medium (DMEM), Dulbecco's phosphate
buffered saline (PBS), and trypsin/ethylenediaminetetraacetic acid
(EDTA) solution were obtained from SigmaeAldrich (St. Louis, MO,
USA). Heparin-binding epidermal growth factor-like growth factor
(HB-EGF) was purchased from R&D Systems (Minneapolis, Minne-
sota, USA). L-Prolinewas obtained from ICN Biomedicals (Aurora, OH,
USA). Nicotinamide was obtained from Kanto Chemicals (Tokyo,
Japan). Epidermal growth factor (EGF) and penicillin/streptomycin
were obtained from Invitrogen (Carlsbad, CA, USA). Fetal bovine
serum (FBS) was obtained from Japan Bioserum (Nagoya, Japan).
[125I]-labeled HB-EGF (191 Ci/mg) was obtained from Anawa (Wan-
gen, Switzerland). The ultrapure water used for all experiments was
prepared by an ultrapure water puriﬁcation system (synthesis A10;
Millipore, Billerica, MA, USA). Male Wistar rats from 5 to 6 weeks of
age were purchased from Japan Laboratory Animals (Tokyo, Japan)
and used for isolating primary hepatocytes. The rats were housed
under temperature-controlled conditions with a 12-h light/dark
cycle and also had ad libitum access to rat chowandwater. All animal
experiments were approved by the Animal Care and Use Committee
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Fig. 1. Schematic illustration of the process for fabricating hepatocyte sheets in (a) afﬁnity-bound HB-EGF and (b) soluble HB-EGF culture systems. HB-EGF indicates heparin-
binding EGF-like growth factor. Primary rat hepatocytes were cultured on an HB-EGF-bound heparin-modiﬁed thermoresponsive surface and a PIPAAm surface with the addi-
tion of soluble HB-EGF and heparin at 37 C. The culture medium was replaced with new medium on the 1st and 3rd days. After a 4-day incubation, cultured hepatocytes were
harvested from theses surfaces after lowering the temperature to 20 C.
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with the institutional guidelines for Tokyo Women's Medical Uni-
versity on Animal Use.2.2. Afﬁnity-binding of HB-EGF on heparin-modiﬁed
thermoresponsive surfaces
Heparin-modiﬁed thermoresponsive surfaces were prepared as
previously described [6]. First, a 55% wt monomer solution (28 mL)
containing IPAAm and CIPAAm (99:1 M ratio) in 2-propanol was
spread on TCPS (culture area: 8.8 cm2). Then, polymerization and
covalent grafting of the polymer on the TCPS surface was carried
out by electron beam irradiation from an area beam electron-
processing system (Curetron EBC-200-AA2; Nissin High Voltage,
Kyoto, Japan), resulting in the grafting of poly(IPAAm-co-CIPAAm)
on TCPS (IC). After washing with water and drying, heparin was
covalently tethered onto IC surfaces through a condensation reac-
tion with carboxyl groups [26,27]. Finally, 2 mL of HB-EGF solution
(10, 50, 100, or 1000 ng/cm2) was added on the heparin-modiﬁed
surfaces (Heparin-IC), which were then incubated at 37 C for
24 h to obtain HB-EGF afﬁnity-bound heparin-IC (HB-EGF/heparin-
IC). All handling of the HB-EGF solution, such as dilutions, was
carried out using Sapphire low retention pipette tips (Greiner,
Frickenhausen, Germany) in Sumilon Proteosave SS microtubes
(Sumitomo Bakelite, Tokyo, Japan) to reduce nonspeciﬁc
adsorption.2.3. Quantitative analysis of afﬁnity-bound HB-EGF on
thermoresponsive surfaces
The amount of afﬁnity-bound HB-EGF on heparin-IC was
quantiﬁed with [125I]-labeled HB-EGF. A mixture of traces of [125I]-
labeled HB-EGF and unlabeled HB-EGF was diluted with PBS using
Sapphire low retention pipette tips (Greiner) in Sumilon Proteosave
tubes (Sumitomo Bakelite) to ﬁnal concentrations of 10, 50, 100, or
1000 ng/mL and then added to heparin-IC for 24 h at 37 C. After
being washed with an excess volume of PBS, the radioactivity of
afﬁnity-bound [125I]-labeled HB-EGF on heparin-IC was measured
by a gamma counting instrument (50-Well gamma system ARC-
950) (Hitachi-Aloka Medical, Tokyo, Japan). To quantify the levels
of afﬁnity-bound HB-EGF, a calibration curve of [125I]-labeled HB-EGF standards was established with known-concentrations of HB-
EGF.
2.4. Hepatocyte isolation and cultivation
Isolation of hepatocytes from a rat liver was carried out by a
modiﬁed two-step collagenase perfusion method as previously
described [15] and was followed by puriﬁcation with 45% Percoll
density centrifugation. Hepatocytes were seeded on IC, heparin-IC,
and HB-EGF/heparin-IC at a cell density of 1.0  105 cells/cm2.
Hepatocytes were cultured with DMEM supplemented with
1  107 mol/L dexamethasone, 0.5 mg/mL insulin, 30 mg/mL L-
proline, 10 mmol/L nicotinamide, 0.2 mmol/L ascorbic acid-2
phosphate, 10% fetal bovine serum, 100 IU/mL penicillin, and
100 mg/mL streptomycin at 37 C in a humidiﬁed atmosphere with
5% CO2. The culture medium was refreshed with new medium on
days 1 and 3.
Cell morphologies were recorded with a phase contrast micro-
scope (Eclipse TE2000-U; Nikon, Tokyo, Japan) equipped with a
digital camera (DXM1200C; Nikon). The hepatocyte density on each
cell culture surface was determined at one day intervals with a
disposable cell counter after removal of the cells from the surface
by trypsin/EDTA treatment. The detachment time of hepatocytes
from the culture surfaces was measured by monitoring attachment
at 10 min intervals after the surfaces were transferred to a 5% CO2
incubator at 20 C.
2.5. Fluorescence staining of a hepatic cell-sheet detached from an
HB-EGF/heparin modiﬁed thermoresponsive cell culture surface
After the temperature was reduced to 20 C from 37 C, hepa-
tocyte sheets were harvested from HB-EGF/heparin-IC and were
ﬁxed in PBS containing 4% paraformaldehyde for 15 min. The ﬁxed
cell sheets were blocked with TNB buffer (PerkinElmer Life and
Analytical Sciences, Waltham, MA, USA) for 30 min at room tem-
perature and washed with a washing buffer of 0.05% Tween-20 in
PBS. The cell sheets were immunostained with a TSA system (Per-
kinElmer Life and Analytical Sciences) to facilitate the visualization
of an extremely small amount of HB-EGF. The cell sheets were
labeled with biotinylated anti-human HB-EGF goat antibody
(1:1000) (R&D system, Minneapolis, USA) as a primary antibody in
TNB buffer overnight at 4 C and washed with washing buffer.
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peroxidase-conjugated streptavidin (1:2000 in TNB buffer,
30 min at room temperature) and washed with washing buffer. The
cell sheets were treated with biotin-labeled tyramide derivative
solution (1:50 in ampliﬁcation diluent, 8min at room temperature).
After being washed with washing buffer, the cell sheets were
stained with AlexaFluor® 488-conjugated streptavidin (1:500)
(Invitrogen, Carlsbad, CA, USA) in TNB buffer for 30 min at room
temperature and washed with the washing buffer. For ﬁbronectin
staining, the cell sheets were incubated with rabbit polyclonal anti-
bovine ﬁbronectin (1:200, Abcam, Cambridge, MA, USA) at room
temperature for 2 h. After being washed with washing buffer, the
cell sheets were incubated with AlexaFluor® 568-conjugated goat
anti-rabbit IgG (1:800, Invitrogen) for 1 h at room temperature and
washed with washing buffer. After the cell sheets were washed
with washing buffer, the ﬂuorescence images of the stained cell
sheets were obtained with a ﬂuorescence microscope (Eclipse
TE2000-U) and processed with AxioVision 4.6 software (Carl Zeiss,
Jena, Germany).
2.6. Quantitative determination of albumin secretion
Albumin secretion from cultured hepatocytes was measured
over the four days of cultivation. On HB-EGF afﬁnity-bound
heparin-IC (HB-EGF 76.2 ng/cm2) and collagen type I coated TCPS
(collagen-TCPS; Iwaki Glass, Chiba, Japan), hepatocytes were
cultured in a culture medium with or without soluble EGF (10 ng/
mL). Hepatocytes on PIPAAm were cultured in culture medium
containing both soluble heparin (1.0 mg/cm2) and soluble HB-EGF
(100 ng/cm2) with or without soluble EGF (10 ng/mL). Albumin
secreted into the culture medium was collected at 24 h intervals
and quantiﬁed with the rat albumin ELISA Quantitation kit (Bethyl
Laboratories, Montgomery, TX, USA).
2.7. Quantitative reverse transcription polymerase chain reaction
(RT-PCR)
Total RNA from each hepatocyte sheet was extracted using
RNeasy Mini Kit (Qiagen, Hilden, Germany). Reverse transcription
was performed with an Omniscript RT Kit (Qiagen). Quantitative
RT-PCR was performed with TaqMan® Fast Advanced Master Mix
and TaqMan® Gene Expression Assay (Applied Biosystems, Foster
City, CA, USA) using ViiA7 Real-Time PCR System (Applied Bio-
systems). The TaqMan® Gene Expression Assay probes were used as
follows: rat b-actin (Actb, Rn00667869_m1), rat albumin (Alb,
Rn00592480_m1), rat hepatocyte nuclear factor 4, alpha (Hnf4a,
Rn00573309_m1), rat coagulation factor VII (F7, Rn00596104_m1),
and rat coagulation factor IX (F9, Rn01451633_m1). Relative mRNA
expressions in each sample were determined by comparative CT
(DDCT) method and normalized to Actb expression. The PCR cycling
conditions for all reactions were 10 min at 95 C, followed by 40
cycles of 15 s at 95 C, and 1 min at 60 C.
3. Results
3.1. Estimation of the quantity and stability of bound HB-EGF on the
heparin-modiﬁed thermoresponsive surface
HB-EGF was introduced through an afﬁnity interaction with
heparin, which was covalently immobilized on poly(IPAAm-co-
CIPAAm)-grafted TCPS (IC). The levels of afﬁnity-bound HB-EGF on
heparin-modiﬁed IC (heparin-IC) were determined with [125I]-
labeled HB-EGF and were found to be 241.2 ± 36.1, 76.2 ± 3.8,
45.4 ± 7.7 10.3 ± 2.3 ng/cm2 when 1000, 100, 50, 10 ng/cm2 soluble
HB-EGF, respectively, was added (Fig. 2a). These surfaces aredenoted “HB-EGFX/heparin-IC”, where X indicates the amount of
afﬁnity-bound HB-EGF. To evaluate the stability of afﬁnity-bound
HB-EGF on heparin-IC, the amounts of HB-EGF were estimated by
monitoring the levels of HB-EGF eluted into the 10% FBS-containing
medium at one-day intervals. After incubation for four days, the
amount of afﬁnity-bound HB-EGF on heparin-IC was maintained at
more than 85.5% of the levels on day 0, excluding the HB-EGF241/
heparin-IC surface, which lost 21.3% of its immobilized HB-EGF
(Fig. 2b).
3.2. The effect of afﬁnity-bound HB-EGF on the heparin-modiﬁed
thermoresponsive surface and hepatocyte culture
Typically, the in vitro cultivation of primary rat hepatocytes
requires ECMs, such as collagen type I, on the culture surface and
soluble epidermal growth factor (EGF) supplementation of the
culture medium [15,28]. To evaluate the effects of tethered
growth factor on hepatocytes, the hepatocytes were cultured on
HB-EGF/heparin-IC without soluble growth factors and on
PIPAAm-grafted surfaces with both soluble heparin (1.0 mg/cm2)
and soluble HB-EGF as a replacement for EGF. The PIPAAm sur-
faces with soluble heparin and HB-EGF are denoted
“PIPAAm þ HB-EGFY”, where Y indicates the amount of soluble
HB-EGF. The amount of soluble heparin was almost comparable
to that of covalently immobilized heparin on the IC surface (i.e.,
0.8 ± 0.4 mg/cm2 [6]). As controls, collagen-TCPS, PIPAAm, IC, and
heparin-IC were used under normal culture conditions without
growth factors. The seeding density necessary for achieving the
maximum level of adhered hepatocytes was determined to be
1.0  105 cells/cm2 (Fig. S1 in Supporting Information). All HB-
EGFX/heparin-IC and PIPAAm þ HB-EGF100 surfaces were
completely covered by adhered hepatocytes, and the morphology
of the hepatocytes showed less spread on these surfaces
compared with other surfaces (Fig. 3). Firstly, initial adhesion of
hepatocytes on HB-EGF76/heparin-IC was investigated when
adding soluble EGF in the medium (Fig. S2 in Supporting Infor-
mation). Hepatocytes exhibited low adhesiveness on HB-EGF76/
heparin-IC (the percentage of adhered, 8.0%) after 1.5 h-incuba-
tion. The percentage was decreased to 3.8% in the medium con-
taining 1000 ng/mL of EGF while the results of one-way analysis
of variance (ANOVA) were not signiﬁcant. Therefore, initial
adhesion of hepatocytes on HB-EGF bound heparin-modiﬁed
thermoresponsive surfaces was partially inhibited by the pres-
ence of soluble EGF. In addition, the densities of the adhered
hepatocytes on each surface were investigated at one-day in-
tervals for four days. After one-day incubation, the percentage of
adhered hepatocytes on all surfaces was increased to approxi-
mately 60e70% (Fig. 4). These results implied that the adhesion
of hepatocytes on all surfaces was mediated mainly through
physisorbed serum proteins, not through the afﬁnity binding
between immobilized HB-EGF and EGF receptor. Although the
number of adhered hepatocytes on collagen-TCPS, PIPAAm, IC,
and heparin-IC, which contained no HB-EGF, was drastically
decreased (Fig. 4a), the number on HB-EGF76/heparin-IC and
PIPAAm þ HB-EGF100 was maintained for four days (Fig. 4b).
Therefore, tethered or soluble HB-EGF maintained the survival of
hepatocytes during cultivation.
3.3. Cell detachment of hepatocytes from HB-EGF/heparin-modiﬁed
thermoresponsive surfaces is accomplished by reducing the
temperature
After 4 days, cultured rat primary hepatocytes grown at 37 C
on HB-EGFX/heparin-IC and PIPAAm þ HB-EGFY were transferred
to a 20 C CO2 incubator to stimulate detachment of the cells
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Fig. 2. (a) The relationship between added HB-EGF and afﬁnity-bound HB-EGF on heparin-IC surface after incubation at 37 C for 24 h. The amounts of afﬁnity-bound HB-EGF on
heparin-IC were 241.2 ± 36.1 (open square), 76.2 ± 3.8 (open triangle), 45.4 ± 7.7 (open circle), and 10.3 ± 2.3 ng/cm2 (open diamond), when a PBS solution with 1000, 100, 50, and
10 ng/cm2 of soluble HB-EGF was added to these surfaces, respectively. The data are expressed as the mean ± S.D. of triplicate experiments. (b) Time-courses of afﬁnity-bound HB-
EGF on each heparin-IC surfaces in 10% fetal bovine serum-containing medium for 4 days at 37 C. The data are expressed as the mean ± S.D. of triplicate experiments.
Fig. 3. Phase contrast microscopic images of cultured primary rat hepatocytes after a 4-day incubation at 37 C. (a) collagen-coated tissue culture polystyrene (collagen-TCPS),
(b) PIPAAm, (c) IC, (d) heparin-IC, (eeh) HB-EGFX/heparin-IC, and (iek) PIPAAm þ HB-EGFY surfaces. Heparin-IC indicates heparin-modiﬁed poly(N-isopropylacrylamide-co-2-
carboxyisopropylacrylamide) (poly(IPAAm-co-CIPAAm))-grafted tissue culture polystyrene (TCPS). HB-EGF indicates heparin-binding EGF-like growth factor. HB-EGF-bound hep-
arin-IC is denoted “HB-EGFX/heparin-IC”, where X indicates the amounts of afﬁnity-bound HB-EGF. The amounts of afﬁnity-bound HB-EGF on heparin-IC are 241.2 ± 36.1
(e), 76.2 ± 3.8 (f), 45.4 ± 7.7 (g), and 10.3 ± 2.3 ng/cm2 (h). PIPAAm surfaces with added soluble HB-EGF and heparin (1.0 mg/cm2) are denoted “PIPAAm þ HB-EGFY”, where Y
indicates the amount of soluble HB-EGF per addition. The amounts of soluble HB-EGF are 100 (i), 50 (j), and 10 ng/cm2 (k). Scale bars: 100 mm.
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observed on PIPAAm, IC, and heparin-IC control surfaces
(Fig. 5bed) because adhered hepatocytes were sparse on these
surfaces after a 4-day incubation (Fig. 4a). Hepatocytes were
unable to detach from the collagen-TCPS surface (Fig. 5a). On the
afﬁnity-bound HB-EGF surfaces with more than 10 ng/cm2 of HB-
EGF (Fig. 5eeh) and PIPAAm surfaces with more than 50 ng/cm2
of soluble HB-EGF (Fig. 5i and j), hepatocytes were able to con-
nect to each other and be harvested as a cell sheet within 40 min
after lowering of the temperature to 20 C (Table 1). When the
bound HB-EGF was increased, the detachment time of the cell
sheets was accelerated to 10 min (Table 1). On the PIPAAm sur-
face with 10 ng/cm2 of HB-EGF, the fabrication of hepatocyte
sheets was difﬁcult and unsuccessful (Fig. 5k) because the
stimulation with small amounts of soluble HB-EGF was insufﬁ-
cient for maintaining the survival of the hepatocytes during the
four days of cultivation.
To trace the localization of afﬁnity-bound HB-EGF and ECM after
cell detachment from heparin-IC, a harvested hepatocyte sheet and
HB-EGF76/heparin-IC surface were observed by ﬂuorescencemicroscopy after ﬂuorescent staining of ﬁbronectin and HB-EGF.
Fibronectin and HB-EGF were apparent in the detached hepato-
cyte sheet, although these proteins were not detected on the
heparin-IC surface (Fig. 6). The internalization of afﬁnity-bound
HB-EGF by the hepatocytes was suppressed during the two days
of cultivation (Fig. S3 in Supporting Information), indicating that
afﬁnity-bound HB-EGF was located on the cellular surfaces of the
hepatocytes. In contrast, soluble HB-EGF was incorporated into
hepatocytes via receptor-mediated endocytosis of the EGF receptor
(Fig. S3 in Supporting Information) [29].
3.4. Albumin secretion and mRNA expression of hepatocytes on an
HB-EGF/heparin-modiﬁed thermoresponsive surface
To evaluate the effects of afﬁnity-bound HB-EGF on hepatic
functions, the level of albumin secreted into the culture medium on
HB-EGF76/heparin-IC was determined by ELISA (Fig. 7). Although
the albumin secretion from hepatocytes gradually decreased on
PIPAAm þ HB-EGF100 and collagen-TCPS, the secretion on HB-
EGF76/heparin-IC was almost doubled during the 4-day cultivation.
Fig. 4. Time-courses of adhering primary rat hepatocytes on collagen-coated tissue culture polystyrene (Collagen-TCPS, closed square), PIPAAm (closed diamond), IC (closed tri-
angle), heparin-IC (open triangle) (a), and on HB-EGF76/heparin-IC (open circle) and PIPAAm þ HB-EGF100 surfaces (closed circle) (b). Heparin-IC indicates heparin-modiﬁed poly(N-
isopropylacrylamide-co-2-carboxyisopropylacrylamide) (poly(IPAAm-co-CIPAAm))-grafted tissue culture polystyrene (TCPS). HB-EGF indicates heparin-binding EGF-like growth
factor. HB-EGF76/heparin-IC indicates heparin-IC surface with surface-bound HB-EGF (76.2 ± 3.8 ng/cm2). PIPAAm þ HB-EGF100 indicates PIPAAm surfaces with soluble HB-EGF
(100 ng/cm2) and heparin (1.0 mg/cm2) per addition. Hepatocytes were cultured for a 4-day incubation at 37 C. The initial cell density was 1.0  105 cells/cm2. The data are
expressed as the mean ± S.D. of triplicate experiments.
Fig. 5. Photographs of primary rat hepatocytes after reduction of the temperature to 20 C after a 4-day incubation at 37 C. (a) collagen-coated tissue culture polystyrene (collagen-
TCPS), (b) PIPAAm, (c) IC, (d) heparin-IC, (eeh) HB-EGFX/heparin-IC and (iek) PIPAAm þ HB-EGFY surfaces. Heparin-IC indicates heparin-modiﬁed poly(N-isopropylacrylamide-co-2-
carboxyisopropylacrylamide) (poly(IPAAm-co-CIPAAm))-grafted tissue culture polystyrene (TCPS). HB-EGF indicates heparin-binding EGF-like growth factor. HB-EGF-bound hep-
arin-IC surfaces are denoted “HB-EGFX/heparin-IC”, where X indicates the amounts of afﬁnity-bound HB-EGF. The amounts of afﬁnity-bound HB-EGF on heparin-IC are 241.2 ± 36.1
(e), 76.2 ± 3.8 (f), 45.4 ± 7.7 (g), and 10.3 ± 2.3 ng/cm2 (h). PIPAAm surfaces with additive soluble HB-EGF and heparin (1.0 mg/cm2) are coded as “PIPAAm þ HB-EGFY”, where Y
indicates the amount of soluble HB-EGF per addition. The amounts of soluble HB-EGF are 100 (i), 50 (j), and 10 ng/cm2 (k). Scale bars: 10 mm.
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albumin secretion of hepatocytes on HB-EGF76/heparin-IC,
PIPAAmþHB-EGF100 and collagen-TCPS. Therefore, the tethering of
HB-EGF onto the heparin-modiﬁed thermoresponsive surface
effectively maintained albumin secretion from hepatocytes, in
contrast with soluble HB-EGF and/or EGF.
To further investigate the relationship between the level of HB-
EGF and the function of hepatocytes on HB-EGF-bound heparinized
thermoresponsive surfaces (HB-EGFX/heparin-IC) and PIPAAm
surfaces with soluble HB-EGF (PIPAAm þ HB-EGFY), hepatocyte-
speciﬁc gene expression in hepatocytes after a 4-day cultivation
was analyzed by quantitative RT-PCR (Fig. 8). The hepatocyte-speciﬁc genes, albumin (Alb), hepatocyte nuclear factor 4 alpha
(Hnf4a), coagulation factor VII (F7), and coagulation factor IX (F9)
were chosen. When grown on HB-EGF76/heparin-IC, the mRNA
expression of Alb and F7was the highest compared with expression
in other HB-EGF/heparin-ICs, although the gene expression on
PIPAAm þ HB-EGFY remained constant, irrespective of the amount
of soluble HB-EGF. Hnf4a gene expression on HB-EGFX/heparin-IC
increased with rising levels of afﬁnity-bound HB-EGF and was
higher than that observed with PIPAAm þ HB-EGFY. F9 gene
expression on HB-EGFX/heparin-IC was higher, even with small
amounts of afﬁnity-bound HB-EGF, than that on PIPAAm þ HB-
EGFY. These results indicated that the HB-EGF76/heparin-IC surface
Table 1
Amounts of HB-EGF and cell detachment time.
Samplea Amounts of HB-EGF (ng/cm2) Detachment time (min)b
Collagen-TCPS e No detachmentc
PIPAAm e 90
IC e 90
Heparin-IC e 90
HB-EGF241/heparin-IC 241.2 ± 36.1 10
HB-EGF76/heparin-IC 76.2 ± 3.8 10
HB-EGF45/heparin-IC 45.4 ± 7.7 10
HB-EGF10/heparin-IC 10.3 ± 2.3 40
PIPAAm þ HBEGF1000 1000 10
PIPAAm þ HBEGF100 100 10
PIPAAm þ HBEGF10 10 40
a As control surfaces, collagen coated-tissue culture polystyrene (collagen-TCPS), poly(N-isopropylacrylamide) grafted TCPS (PIPAAm),
poly(IPAAm-co-CIPAAm)-grafted TCPS (IC), and heparin-immobilized IC (heparin-IC) were used. HB-EGF indicates heparin-binding EGF
like growth factor. HB-EGF-bound heparin-IC is denoted “HB-EGFX/heparin-IC”, where X indicates the amount of afﬁnity-bound HB-EGF.
PIPAAm surfaces with additive soluble HB-EGF and soluble heparin (1.0 mg/cm2) are denoted “PIPAAm þ HB-EGFY”, where Y indicates the
amount of soluble HB-EGF per addition.
b Time required for cell detachment from the substrates after reducing the temperature from 37 to 20 C.
c Cells remained attached on the surfaces over the 120 min at 20 C.
Fig. 6. Phase contrast and ﬂuorescence microscopy images of a harvested primary rat hepatocyte sheet from HB-EGF76/heparin-IC surface that was harvested after reduction of the
temperature to 20 C. (a) After a 4-day cultivation at 37 C, hepatocytes were detached as a monolayer by reduction of the temperature to 20 C and observed by a phase-contrast
microscope. Harvested hepatocyte sheets were ﬁxed with 4% performaldehyde. Fibronectin (FN) and HB-EGF on the cell-sheet and the surface were stained with (b) AlexaFluor®
568 (red) and (c) AlexaFluor® 488 (green), respectively. The merged image (d) was created by the superimposition of FN (red) and HB-EGF (green) ﬂuorescent images. Scale bars:
100 mm. HB-EGF and heparin-IC indicate heparin-binding EGF-like growth factor and heparin-modiﬁed poly(N-isopropylacrylamide-co-2-carboxyisopropylacrylamide) (poly(-
IPAAm-co-CIPAAm))-grafted tissue culture polystyrene (TCPS), respectively. HB-EGF76/heparin-IC indicates heparin-IC surface with surface-bound HB-EGF (76.2 ± 3.8 ng/cm2).
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HB-EGFX/heparin-ICs and PIPAAm þ HB-EGFY.
4. Discussion
Mono-cultivation of hepatocytes, while maintaining their sur-
vival, is quite difﬁcult on synthetic polymer-based cell culture
substrates, including polystyrene and thermoresponsive surfaces.
Hepatocytes can rapidly lose their normal cellular morphology and
cell-speciﬁc functions. In this study, we combined a thermores-
ponsive surface with bioactive heparin molecules to achieve both
the maintenance of hepatic functions and recovery of the hepato-
cyte sheet. In a previous study, we have reported that a heparin-
modiﬁed thermoresponsive surface bound with bFGF enhancesthe proliferation of ﬁbroblasts and enables the cultured cell-sheets
to be detached. Moreover, after the temperature is reduced from 37
to 20 C, this detachment is accompanied by dynamic motion of the
heparin molecules and conformational change of the hydrated
PIPAAm chains [6].
The present work demonstrated that immobilized heparin on a
thermoresponsive surface stably held HB-EGF via afﬁnity-binding
(Fig. 9, left) and maintained the survival and functionality of he-
patocytes. HB-EGF shows a high afﬁnity interaction with heparin
[18e20]. Therefore, HB-EGF was able to bind to heparin immobi-
lized on a thermoresponsive surface in 10% FBS-containingmedium
for 4 days (Fig. 2b), which was the minimum time required for
fabricating hepatocyte sheets. When grown on HB-EGF76/heparin-
IC and PIPAAmþHB-EGF100, the number of hepatocytes was almost
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Fig. 7. Albumin secretion from cultured primary rat hepatocytes during a 4-day in-
cubation was measured by enzyme-linked immunosorbent assay (ELISA). Hepatocytes
were cultured on HB-EGF76/heparin-IC (circle), PIPAAm þ HB-EGF100 (triangle), and
collagen coated tissue culture polystyrene surfaces (diamond) under culture conditions
with added epidermal growth factor (EGF, 10 ng/mL, open symbol), and without EGF
(closed symbols). To measure rat albumin secretion, culture medium was collected
from each sampling tube at 24 h intervals and replenished each time. The data are
expressed as the mean ± S.D. from triplicate experiments. HB-EGF and heparin-IC
indicate heparin-binding EGF-like growth factor and heparin-modiﬁed poly(N-iso-
propylacrylamide-co-2-carboxyisopropylacrylamide) (poly(IPAAm-co-CIPAAm))-graf-
ted tissue culture polystyrene (TCPS), respectively. HB-EGF76/heparin-IC indicates
heparin-IC surface with surface-bound HB-EGF (76.2 ± 3.8 ng/cm2). PIPAAm þ HB-
EGF100 indicates PIPAAm surfaces with soluble HB-EGF (100 ng/cm2) and heparin
(1.0 mg/cm2) per the addition of the medium.
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This result indicated that the presence of afﬁnity-bound HB-EGF or
soluble HB-EGF could greatly contribute to hepatocyte survival. In
addition, HB-EGF tethered onto the cell culture surfaces, compared
with soluble HB-EGF in culture medium, strongly stimulated the
cultured hepatocytes over a long period. When the medium con-
tained less than 10 ng/cm2 of soluble HB-EGF, the hepatocytes were
not able to adhere and form their cell sheets (Fig. 5k). In contrast,
hepatocytes adhered and formed sheets on a heparin-modiﬁed
thermoresponsive surface containing 10.3 ng/cm2 of bound HB-
EGF (Fig. 5h). Hence, lower amounts of bound HB-EGF, as
compared to soluble HB-EGF, on heparin-modiﬁed surfaces were
sufﬁcient for hepatocyte survival.
With respect to hepatic functions, soluble HB-EGF in the culture
medium poorly stimulated albumin secretion from hepatocytes, as
compared with the effects of afﬁnity-bound HB-EGF on heparin-IC
(Fig. 7). In general, the addition of soluble EGF (10 ng/mL) is
absolutely necessary for the survival of primary hepatocytes and
the maintenance of their function in vitro [15,28]. However, HB-
EGF76/heparin-IC effectively enhanced the albumin secretion from
hepatocyte sheets in the absence of soluble EGF. These results
implied that afﬁnity-bound HB-EGFs on a surface more strongly
activate the intracellular signal transduction pathways than does
the addition of soluble EGF and/or HB-EGF, owing to the inhibition
of down-regulation of their signaling via receptor-mediated
endocytosis on afﬁnity-bound HB-EGF surfaces (Fig. S2 in
Supporting Information). Similarly, hepatocyte mRNA expression
of Alb, Hnf4a, F7 and F9 on HB-EGF/heparin-IC surfaces was
signiﬁcantly higher than that on other surfaces with soluble HB-
EGF (Fig. 8). These results indicated that dedifferentiation ofcultured hepatocytes on HB-EGF/heparin-IC surfaces was sup-
pressed. Therefore, heparin-modiﬁed thermoresponsive surfaces
bound with HB-EGF contributed to the maintenance of highly
differentiated status of cultured hepatocytes.
A culture system for hepatocyte sheets using heparin-modiﬁed
thermoresponsive surfaces was able to reduce the total amounts
of required HB-EGF. Typically, 88 ng of HB-EGF was used for pre-
paring HB-EGF76/heparin-IC with the surface area of 8.8 cm2. No
additional HB-EGF in the medium was required. By contrast, the
amounts of HB-EGF on PIPAAm þ HB-EGF100 for a 4-day cultivation
was three times than that on HB-EGF76/heparin-IC because the
frequent exchange of the medium containing soluble HB-EGF was
done at days 0, 1, and 3. In addition, the amount of albumin
secretion from hepatocytes (Fig. 7) and mRNA expressions of he-
patocytes (Fig. 8) on HB-EGF/heparin-IC surfaces were signiﬁcantly
higher than that on PIPAAm surfaces with soluble HB-EGF. There-
fore, heparin-modiﬁed thermoresponsive surfaces is a cost-
effective tool for preparing functional hepatocyte sheets.
Another factor for the maintenance of hepatic function is the
interaction with the ECM. In the native liver, the hepatic peri-
sinusoidal space between hepatocytes and endothelial cells con-
tains ECMs including collagen, ﬁbronectin, and proteoglycans such
as decorin and perlecan [30,31]. Hepatocytes are unable to syn-
thesize decorin and perlecan, which are provided from endothelial
and hepatic stellate cells [31]. In a coculture system of hepatocytes
and non-parenchymal cells, decorin contributes to the up-
regulation of liver-speciﬁc functions [32]. However, the mono-
culture of hepatocyte sheets on thermoresponsive PIPAAm surfaces
lacks proteoglycans. Our previous report has suggested that an
endothelial cell sheet layered onto a hepatocyte sheet provides the
endothelial cell-derived ECMs between the endothelial cell and the
hepatocyte sheets, and the presence of ECMs would preserve the
hepatic functions [15]. In the present paper, the presence of heparin
molecules on the thermoresponsive surfaces would provide an
ECM-mimicking structure in the hepatic perisinusoidal space and
contribute to the maintenance of hepatic functions. However, the
amount of albumin secretion from hepatocytes on HB-EGF bound
surfaces in the current work was less than that from the coculture
system of hepatocyte and non-parenchymal cell sheets [15].
Therefore, further investigations of molecular mechanism of
maintaining hepatic phenotype and functions are required for
achieving a complete monoculture system for hepatocyte sheets
using synthetic polymer substrate.
Finally, heparin-modiﬁed thermoresponsive surfaces facilitated
the fabrication of hepatocyte sheets in which hepatic functions
were maintained, and the sheets could be transferred only by
reducing the temperature to 20 C. The adhered hepatocytes were
able to be harvested as a hepatocyte sheet from the HB-EGF/
heparin-IC by lowering the temperature to 20 C. We conﬁrmed
that afﬁnity-bound HB-EGF and ﬁbronectin were transferred from
the HB-EGF/heparin-IC surface to the basal side of the cell sheet
during the detachment of the cell sheet (Fig. 6). These results
showed that cultured hepatocytes were able to detach from HB-
EGF/heparin-IC surfaces through the reduction of afﬁnity-binding
between HB-EGF and immobilized heparin when the mobility of
heparin and the steric hindrance of the swollen PIPAAm chains
were increased by lowering the temperature to 20 C (Fig. 9, right).
5. Conclusions
Heparin-modiﬁed thermoresponsive surfaces bound with HB-
EGF (HB-EGF/heparin-IC) were designed for the purpose of
creating hepatocyte sheets while maintaining hepatic cell func-
tions. Heparin-modiﬁed thermoresponsive surfaces facilitated the
stable binding of HB-EGF, which maintained the survival and
4fnHblA α
9F7F
Amount of HB-EGF 
(ng/cm2)
R
el
at
iv
e m
R
N
A
 le
ve
l
(N
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
2
100 200 3000
4
6
8
0
10
Amount of HB-EGF 
(ng/cm2)
R
el
at
iv
e m
R
N
A
 le
ve
l
(N
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
0.2
100 200 3000
0.4
0.6
0.8
0.0
1.0
Amount of HB-EGF 
(ng/cm2)
R
el
at
iv
e 
m
R
N
A
 le
ve
l
(N
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
0.005
100 200 3000
0.010
0.015
0.020
0.000
0.025
Amount of HB-EGF 
(ng/cm2)
R
el
at
iv
e m
R
N
A
 le
ve
l
(N
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
0.01
100 200 3000
0.02
0.03
0.04
0.00
0.05
Fig. 8. Hepatocyte-speciﬁc gene expression in harvested hepatocyte sheets. The hepatocyte sheets were harvested from HB-EGFX/heparin-IC surfaces (opened circles) and
PIPAAmY þ HB-EGF surfaces (closed circles) after a 4-day cultivation at 37 C. Gene expression levels of albumin (Alb), hepatocyte nuclear factor 4 alpha (Hnf4a), coagulation factor
VII (F7) and coagulation factor IX (F9) were determined by quantitative RTePCR. All the data are normalized to mRNA expression level of beta-actin (Actb) and are expressed as the
mean ± S.D. of triplicate experiments. HB-EGF and heparin-IC indicate heparin-binding EGF-like growth factor and heparin-immobilized poly(N-isopropylacrylamide-co-2-
carboxyisopropylacrylamide) (poly(IPAAm-co-CIPAAm))-grafted tissue culture polystyrene (TCPS), respectively. HB-EGFX/heparin-IC indicates heparin-IC surface with different
amounts of afﬁnity-bound HB-EGF. The amounts of afﬁnity-bound HB-EGF on heparin-IC are 241.2 ± 36.1, 76.2 ± 3.8, 45.4 ± 7.7, and 10.3 ± 2.3 ng/cm2. PIPAAm þ HB-EGFY indicates
PIPAAm surfaces with different amounts of soluble HB-EGF in culture medium containing heparin (1.0 mg/cm2). The total soluble HB-EGF amounts of PIPAAmY þ HB-EGF for a 4-day
cultivation are 300, 150, 30 ng/cm2 (as amounts of soluble HB-EGF per addition: 100, 50, 10 ng/cm2, respectively).
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Fig. 9. Schematic illustration of temperature-dependent afﬁnity regulation on a hepatocyte, HB-EGF, and heparin-immobilized thermoresponsive surface. Left, at 37 C regular
culture temperature (37 C), adhesion and survival of cultured rat hepatocytes maintained on a surface that immobilizes HB-EGF through the afﬁnity-binding of heparin with
shrunken thermoresponsive polymer chains. Right, after lowering the temperature to 20 C, the cultured hepatocytes detach due to an increase in the steric hindrance of the
swollen grafted thermoresponsive polymer chains. HB-EGF is transferred from the surface to the detached hepatocytes because of its afﬁnity-binding to EGF receptors.
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bumin secreted from hepatocytes on HB-EGF/heparin-IC surfaces
was almost twice that observedwith soluble growth factors. During
a 4-day cultivation of hepatocytes, no additional HB-EGF supple-
mentation of the medium was required on HB-EGF/heparin-IC
surfaces, whereas the frequency of soluble HB-EGF dosing was
three times that on PIPAAm surfaces. More importantly, the
transplantation of hepatocyte sheets while hepatic functions were
maintained was possible through use of HB-EGF/heparin-IC sur-
faces. Heparin-modiﬁed thermoresponsive surfaces bound with
HB-EGF have the potential to provide a functional hepatocyte
sheet-based culture system and effective hepatocyte-based tissue
engineering for the treatment of liver diseases.
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